1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. CYTOMX THERAPEUTICS INC
CytomX Therapeutics Inc
XNAS: CTMX

CytomX Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Await Turnaround
about

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics...

Read More
4.63 -0.24 (-4.93%)
27.09% Fall from 52W High
1.8M
XNAS Volume

XNAS 13 Mar, 2026 1:05 PM (EDT)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for CytomX Therapeutics Inc is on 16 Mar 2026 for the purpose of CytomX Therapeutics Inc Fourth Quarter Earnings Result for 2025 See details
Durability score
Low Financial Strength
33.3 / 100
Valuation Score
Mid Valuation
35.5 / 100
Momentum Score
Technically Neutral
59.0 / 100
Await Turnaround These stocks have poor financials and average valuation and momentum. Investors should be cautious about these stocks View Similar Embed DVM
Analyst Price Target
9
1Yr Price target upside is 94%
9 analysts

8

S

15

W

6

O

0

T

SWOT Analysis

CytomX Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..